Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

1.

H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination.

Moody MA, Zhang R, Walter EB, Woods CW, Ginsburg GS, McClain MT, Denny TN, Chen X, Munshaw S, Marshall DJ, Whitesides JF, Drinker MS, Amos JD, Gurley TC, Eudailey JA, Foulger A, DeRosa KR, Parks R, Meyerhoff RR, Yu JS, Kozink DM, Barefoot BE, Ramsburg EA, Khurana S, Golding H, Vandergrift NA, Alam SM, Tomaras GD, Kepler TB, Kelsoe G, Liao HX, Haynes BF.

PLoS One. 2011;6(10):e25797. doi: 10.1371/journal.pone.0025797. Epub 2011 Oct 19.

PMID:
22039424
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.

Jegaskanda S, Amarasena TH, Laurie KL, Tan HX, Butler J, Parsons MS, Alcantara S, Petravic J, Davenport MP, Hurt AC, Reading PC, Kent SJ.

J Virol. 2013 Dec;87(24):13706-18. doi: 10.1128/JVI.01666-13. Epub 2013 Oct 9.

PMID:
24109221
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.

Li GM, Chiu C, Wrammert J, McCausland M, Andrews SF, Zheng NY, Lee JH, Huang M, Qu X, Edupuganti S, Mulligan M, Das SR, Yewdell JW, Mehta AK, Wilson PC, Ahmed R.

Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9047-52. doi: 10.1073/pnas.1118979109. Epub 2012 May 21.

PMID:
22615367
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Apr 13;61(14):237-41.

PMID:
22495226
[PubMed - indexed for MEDLINE]
Free Article
5.

Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.

Bragstad K, Martel CJ, Thomsen JS, Jensen KL, Nielsen LP, Aasted B, Fomsgaard A.

Influenza Other Respir Viruses. 2011 Jan;5(1):13-23. doi: 10.1111/j.1750-2659.2010.00177.x. Epub 2010 Nov 3.

PMID:
21138536
[PubMed - indexed for MEDLINE]
6.

1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans.

Miller MS, Tsibane T, Krammer F, Hai R, Rahmat S, Basler CF, Palese P.

J Infect Dis. 2013 Jan 1;207(1):98-105. doi: 10.1093/infdis/jis652. Epub 2012 Oct 18.

PMID:
23087428
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.

Yoshida R, Igarashi M, Ozaki H, Kishida N, Tomabechi D, Kida H, Ito K, Takada A.

PLoS Pathog. 2009 Mar;5(3):e1000350. doi: 10.1371/journal.ppat.1000350. Epub 2009 Mar 20.

PMID:
19300497
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.

Whittle JR, Wheatley AK, Wu L, Lingwood D, Kanekiyo M, Ma SS, Narpala SR, Yassine HM, Frank GM, Yewdell JW, Ledgerwood JE, Wei CJ, McDermott AB, Graham BS, Koup RA, Nabel GJ.

J Virol. 2014 Apr;88(8):4047-57. doi: 10.1128/JVI.03422-13. Epub 2014 Feb 5.

PMID:
24501410
[PubMed - indexed for MEDLINE]
9.

A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.

Marcelin G, DuBois R, Rubrum A, Russell CJ, McElhaney JE, Webby RJ.

PLoS One. 2011;6(10):e26335. doi: 10.1371/journal.pone.0026335. Epub 2011 Oct 24.

PMID:
22039464
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.

Madhi SA, Dittmer S, Kuwanda L, Venter M, Cassim H, Lazarus E, Thomas T, Liberty A, Treurnich F, Cutland CL, Weinberg A, Violari A.

AIDS. 2013 Jan 28;27(3):369-79. doi: 10.1097/QAD.0b013e32835ab5b2.

PMID:
23032417
[PubMed - indexed for MEDLINE]
11.

Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.

Straight TM, Ottolini MG, Prince GA, Eichelberger MC.

Virol J. 2008 Mar 20;5:44. doi: 10.1186/1743-422X-5-44.

PMID:
18355405
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.

Pediatrics. 2006 Sep;118(3):e579-85.

PMID:
16950949
[PubMed - indexed for MEDLINE]
Free Article
13.

Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).

Skowronski DM, Janjua NZ, De Serres G, Purych D, Gilca V, Scheifele DW, Dionne M, Sabaiduc S, Gardy JL, Li G, Bastien N, Petric M, Boivin G, Li Y.

J Infect Dis. 2012 Dec 15;206(12):1852-61. doi: 10.1093/infdis/jis500. Epub 2012 Aug 7.

PMID:
22872731
[PubMed - indexed for MEDLINE]
Free Article
14.

Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets.

Pearce MB, Belser JA, Gustin KM, Pappas C, Houser KV, Sun X, Maines TR, Pantin-Jackwood MJ, Katz JM, Tumpey TM.

J Virol. 2012 Jul;86(13):7118-25. doi: 10.1128/JVI.00674-12. Epub 2012 May 2.

PMID:
22553323
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.

Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, Nabel GJ.

Science. 2010 Aug 27;329(5995):1060-4. doi: 10.1126/science.1192517. Epub 2010 Jul 15.

PMID:
20647428
[PubMed - indexed for MEDLINE]
Free Article
16.

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.

King JC Jr, Cox MM, Reisinger K, Hedrick J, Graham I, Patriarca P.

Vaccine. 2009 Nov 5;27(47):6589-94. doi: 10.1016/j.vaccine.2009.08.032. Epub 2009 Aug 27.

PMID:
19716456
[PubMed - indexed for MEDLINE]
17.

Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Wang S, Taaffe J, Parker C, Solórzano A, Cao H, García-Sastre A, Lu S.

J Virol. 2006 Dec;80(23):11628-37. Epub 2006 Sep 20.

PMID:
16987975
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.

Ansaldi F, Canepa P, Ceravolo A, Valle L, de Florentiis D, Oomen R, Vogel FR, Denis M, Samson SI, Icardi G.

Vaccine. 2012 Apr 16;30(18):2908-13. doi: 10.1016/j.vaccine.2012.02.003. Epub 2012 Feb 15.

PMID:
22342501
[PubMed - indexed for MEDLINE]
19.

Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.

Leroux-Roels I, Vets E, Freese R, Seiberling M, Weber F, Salamand C, Leroux-Roels G.

Vaccine. 2008 Dec 2;26(51):6614-9. doi: 10.1016/j.vaccine.2008.09.078. Erratum in: Vaccine. 2010 Nov 23;28(50):8033.

PMID:
18930093
[PubMed - indexed for MEDLINE]
20.

Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice.

Muramatsu M, Yoshida R, Miyamoto H, Tomabechi D, Kajihara M, Maruyama J, Kimura T, Manzoor R, Ito K, Takada A.

PLoS One. 2013 Aug 16;8(8):e71534. doi: 10.1371/journal.pone.0071534. eCollection 2013.

PMID:
23977065
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk